Medical Cannabis Market Share, Size, Trends, Growth | Industry Research Report By 2024

1. Global Medical Cannabis Market Report, Share, Size and Forecast Till 2023 Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. About IMARC Group Report Description IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Medical Cannabis Market Report By Species (Indica, Sativa and Hybrid), Application (Cancer, Arthritis, Migraine, Epilepsy and Others), Derivative, Route of Administration, Region The global medical cannabis market has been witnessing a robust growth over the past few years. This can be accredited to the aging population, mounting investments in R&D activities and an increase in the number of countries which are legalising the use of cannabis for medical purposes. Market Overview: According to the recent report by IMARC Group, titled “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global medical cannabis market reached a value of more than US$ 11 Billion in 2017. Medical cannabis is currently in an introductory phase in the pharmaceutical industry and is gradually gaining acceptance across the globe. It is prescribed by doctors in the form of smoke, vapour and liquid extracts so as to alleviate the symptoms of various conditions or diseases like depression, migraine, chronic pain, arthritis, multiple sclerosis, nerve damage, anxiety, epilepsy, Parkinson’s disease, PTSD, etc. In comparison with the recreational cannabis, medical cannabis has a higher amount of Cannabidiol (CBD) and lower count of Tetrahydrocannabinol (THC) which helps in retaining anti-psychotic effects and providing therapeutic advantages to patients.

4. Report Description and Highlights Report Description • On account of anti-proliferative and anti-spasmodic effects of medical cannabis, several countries are legally approving its employment in the treatment of various health conditions. For instance, medical cannabis is now used for reducing nausea and increasing the appetite of chemotherapy patients. Besides this, as aging population is more likely to develop chronic diseases, it plays a vital role in strengthening the growth of the medical cannabis market. Some of the other major factors which are boosting the market growth include inflating disposable incomes, urbanisation, and high investment in clinical trials as well as research and development activities so as to develop safer forms of cannabis. Looking forward, the market value is projected to reach nearly US$ 37 Billion by 2023, expanding at a CAGR of 22% during 2018-2023. • Medical Cannabis Market Segmentation: • Market Segmentation by Species • Indica • Sativa • Hybrid • On the basis of species, the market has been segmented into Indica, Sativa and Hybrid. Presently, Indica cannabis dominates the market as it is used for treating insomnia and relieving body pain, headache and migraine.

5. Market Forecast Sample Figure: Global: Medical Cannabis Market Forecast: Value Trends (in Billion US$), 2018-2023

6. Market Segmentation Report Description • Market Segmentation by Derivative • Cannabidiol (CBD) • Tetrahydrocannabinol (THC) • Others • Based on derivative, the market has been segregated into Cannabidiol (CBD), Tetrahydrocannabinol (THC) and others. Currently, Cannabidiol is widely used for medical purposes as it relatively consists low levels of toxicity. • Market Segmentation by Application • Cancer • Arthritis • Migraine • Epilepsy • Others • On the basis of application, cancer holds the majority of the market share. Other key applications of medical cannabis include arthritis, migraine, epilepsy and others. • For more information, click here: https://www.imarcgroup.com/medical-cannabis-market

7. Market Segmentation Report Description • Market Segmentation by End-Use • Pharmaceutical Industry • Research and Development Centres • Others • Based on end-use, the market has been bifurcated into pharmaceutical industry and development centres. At present, the pharmaceutical industry accounts for the largest market share. • Market Segmentation by Region • Asia Pacific • North America • Europe • Middle East and Africa • Latin America • Region-wise, the market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa. While North America is further classified into the United States and Canada, the European region is segmented into Germany, Italy, France, Netherlands and Spain. Amongst these, North America is the leading market holding the majority of the global share.

8. Regional Segmentation North America Europe Asia- Pacific Middle East and Africa Latin America

9. Market Segmentation Report Description • Market Segmentation by Route of Administration • Oral Solutions and Capsules • Smoking • Vaporizers • Topicals • Others • The market is also divided on the basis of route administration which includes oral solutions and capsules, smoking, vaporizers, topicals and others. Currently, oral solutions and capsules exhibit a clear dominance in the market. • Competitive Landscape: • Canopy Growth Corporation • GW Pharmaceuticals • Aurora Cannabis Inc • Aphria Inc • MedReleaf Corporation • Request for a sample report: https://www.imarcgroup.com/request?type=report&id=1053&flag=B

10. Market Segmentation Report Description • Insys Therapeutics Inc • CanniMed Therapeutics Inc • Cara Therapeutics • United Cannabis Corporation • In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

11. Team Profile Our Team Comes From Some of the Top Universities Globally. Team Profile 60% Engineering and Science 5% Others 35% Business Studies Average Experience of 7+ Years Over 2000 Independent Consultants from different sectors.

12. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

13. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

14. Report Description and Highlights Report Description © 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

15. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com